Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
Read Article
News
2024
2023
Archive
Search news articles
June 15, 2018
Nohla Announces Presentation of Dilanubicel (NLA101) Data at EHA Annual Meeting Showcasing Excellent Long-term Survival Outcomes
June 8, 2018
Phase 2 Study Shows Promising Results for Potential Mucus Clearance Drug
June 7, 2018
Spyryx SPX-101 Phase 2 HOPE-1 Trial Shows Improvement in Lung Function in Patients with Cystic Fibrosis via Novel Modulation of ENaC
June 6, 2018
Nohla Receives EMA PRIME Designation for Dilanubicel (NLA101) to Treat Hematopoietic Stem Cell Transplant Patients
June 5, 2018
Audentes Announces Priority Medicines (PRIME) Designation Granted by the European Medicines Agency to AT132 for the treatment of X-Linked Myotubular Myopathy
May 31, 2018
scPharmaceuticals Inc. Provides Regulatory Update on FUROSCIX®
May 30, 2018
NOUSCOM APPOINTS ADRIAN WOOLFSON, M.D., PH.D AS CHIEF MEDICAL OFFICER
May 22, 2018
CIDARA THERAPEUTICS ANNOUNCES OFFERING OF COMMON STOCK AND WARRANTS
May 21, 2018
CIDARA THERAPEUTICS AND RUTGERS UNIVERSITY AWARDED $5.5 MILLION GRANT FROM NIH
May 17, 2018
Nohla Announces EHA Abstract Acceptance on Dilanubicel (NLA101) Off-the-Shelf Cell Therapy Showing Excellent Long-term Survival Outcomes
« Previous Page
1
…
4
5
6
7
8
…
10
Next Page »